Prospective, parallel-group, randomised, open label, bilateral daily wear study to investigate bacterial contamination of regular contact lens cases when used in conjunction with marketed and investigational contact lens.

CIBA VISIO0 个研究点目标入组 80 人开始时间: 2009年1月27日最近更新: 2020年1月13日

试验速览

暂无简介。

•Be able to read and comprehend English and give informed consent as demonstrated by signing a record of informed consent;
•Be at least 18 years old;
•Be willing to comply with the wearing and clinical trial visit schedule as directed by the investigator;
•Have ocular health findings considered to be 'normal' and which would not prevent the participant from safely wearing contact lenses;
•Be correctable to at least 6/12 (20/40) or better in each eye with contact lenses;
•Be experienced or may be inexperienced at wearing contact lenses

•Pre-existing ocular irritation, injury or condition that would preclude contact lens fitting and safe wearing of contact lenses;
•any systemic disease that adversely affects ocular health;
•any active corneal infection or any active ocular disease that would affect wearing of contact lenses;
•a need for concurrent category S3 and above ocular medication up to 12 weeks prior to and during the trial;
•any systemic medication or topical medications which may alter normal ocular findings/are known to affect a participant’s ocular health/physiology or contact lens performance either in an adverse manner or beneficial manner;
•previous corneal refractive surgery;
•contraindications to contact lens wear;
•currently enrolled in another clinical trial;
•participation in a clinical trial within the previous 2 weeks for dispensing studies;
•pregnant women are excluded from the trial - formal testing of pregnancy is not required. A participant’s verbal report is sufficient.

发起方

CIBA VISIO